Program Descriptions Lecture/Faculty: }} Basic Principles of Mental Status Testing Mario F. Mendez, MD, PhD, FAAN, Los Angeles, CA }} Basics of Memory and Language Examination Bradford Dickerson, MD, Charlestown, MA Core Competencies: Patient Care, Practice-Based Learning and Improvement Teaching Style: Audience Participation, Didactic CME Credits: 2 Recommended Audience: Advanced Practice Provider, General Neurologist, Neurohospitalist, Non-Neurologist, Specialist Neurologist, Trainee
Plenary Session Wednesday, April 25, 2018 9:15 a.m.–11:30 a.m.
Frontiers in Neuroscience Plenary Session Topics:
Sleep; MS and CNS Inflammatory Disease; Aging, Dementia, Cognitive, and Behavioral Neurology; General Neurology; Neuro-rehabilitation; Child Neurology and Developmental Neurology Moderator: Paul M. George, MD, PhD, MSE, Stanford, CA
G
9:35 a.m.–9:55 a.m. }} Does Connectomics Make Sense? Jeff Lichtman, MD, PhD, Cambridge, MA
Course Wednesday, April 25, 2018 1:00 p.m.–3:00 p.m.
C144 Neurology Update I: Epilepsy, Behavioral Neurology, and Neurologic Infections
Topics:
General Neurology; Aging, Dementia, Cognitive, and Behavioral Neurology; Epilepsy/Clinical Neurophysiology (EEG); Infectious Disease Director: Ralph F. Józefowicz, MD, FAAN, Rochester, NY
J
See complete course description on page 82 »
38 2018 AAN Annual Meeting
Aging, Dementia, Cognitive, and Behavioral Neurology
Course Wednesday, April 25, 2018 1:00 p.m.–3:00 p.m.
C145 Severe TBI: From ICU to Rehabilitation Topics:
Neuro-rehabilitation; Aging, Dementia, Cognitive, and Behavioral Neurology; Neuro Trauma, Critical Care, and Sports Neurology Director: Susanne Muehlschlegel, MD, MPH, Worcester, MA
J
See complete course description on page 167 »
Course Wednesday, April 25, 2018 1:00 p.m.–3:00 p.m.
C146 Non-Alzheimer’s Dementia I: Frontotemporal Dementias
Topic: Aging, Dementia, Cognitive, and Behavioral Neurology Director: Gil Dan Rabinovici, MD, San Francisco, CA
J
Program Description: Frontotemporal dementia (FTD) defines a family of disorders that are characterized clinically by progressive changes in social-emotional function (behavioral-variant, bvFTD) or language (non-fluent/agrammatic or semantic variants of primary progressive aphasia, PPA), in the setting of degeneration of the frontal and anterior temporal lobes. FTD is as common as Alzheimer’s disease (AD) in patients presenting with an early-onset dementia (under age 65), and familiarity with the syndromes can help neurologists advise on heritability, prognosis and appropriate treatment. Faculty will present a case-based approach to introduce the diverse clinical presentations of these disorders, and provide an update on biomarker development and advances in understanding the genetic and molecular underpinnings of these disorders. This program complements C161: Non-Alzheimer’s Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias, but covers independent topics. Upon Completion: Participants should be able to apply up-to-date clinical criteria and diagnostic tools to classify the different subtypes of bvFTD and PPA, and differentiate these disorders from atypical presentations of AD. Improving clinical diagnosis and in vivo prediction of molecular pathology is critical in preparation for emerging disease-specific therapies for these disorders. Lecture/Faculty: }} Behavioral-Variant Frontotemporal Dementia Gil Dan Rabinovici, MD, San Francisco, CA }} Primary Progressive Aphasia Faculty Core Competencies: Medical Knowledge, Patient Care Teaching Style: Audience Participation, Case-Based, Didactic, Interactive